Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
cant go down on a day CEO is at white house...?
I read the CEO is flying to DC to be part of the white house briefing tomorrow? Doesnt make sense that this was down today.
GILD + NSPX = adenosine powerhouse!
unlikely to be + .01 by end of day
pre market waterfall, back to 75 today?
called crazy when I said .009
read the iOS reviews, many iHub users have similar stories that we have experienced here....
Etrade would not give me the option to buy something is up here...
Stock dilution, no news, penny pumpers, all keys to sub penny
.009 a good buy? or .005?
What a joke, glad I dumped this POS
Without news valuation from Yahoo is the only reason to buy...
We value Inspyr using a probability-adjusted discounted cash flow model that takes into account potential revenues from the sale of mipsagargin in HCC and GBM, as these two programs are the furthest along in development. We estimate that for HCC, a Phase 3 trial will commence in 2017, an NDA will be filed in 2020, and approval of mipsagargin will occur in 2021. For GBM, we estimate a Phase 3 trial commencing in 2018, with an NDA filing in 2021 and approval in 2022. We model for peak revenues of $600 million in GBM and $2 billion in HCC. Using a 20% discount rate, this leads to a valuation of $0.40.
https://finance.yahoo.com/news/nspx-genspera-changes-name-inspyr-190000916.html
Chris Lowe worked as a temp CFO for many..
Inncenture "Managing Partner" Jan 2017-Mar 2020
Inspyr "Director" Sept 2016-Dec 2018
EpiBiome "Director" May 2016-Jun 2018
FLG "Partner" Jan 2014-Present
Cortexyme "CFO" Jan 2019-Present
Hansen Medical "Interim CEO" Feb 2014-Jul 2016
nothing for years but now onto something?
Lunch .009, I will buy some back
patents were worthless 5 years ago and they are still today.
I'll buy at .0001 and then come tell you how great NSPX is.
When the SEC closes this ticker down, I dont want to get screwed like the other penny stocks pumped here.
This was a PUMP & DUMP. When you see 3 guys pumping a penny stock with no solid anything from the company, RUN! The CEO works IT support. The doctors are retired and only keep the company open so they have a title. John Hopkins would not use their treatments years ago and they won't ever.
Out! 10 k lost.
For sub .01?
would love to see anything positive happen. A few pumpers are left so if I could break even at .021 take my 10k and run!
Sabby paid the 250k was the story last week. Obviously sabby has some interest in manipulating the stock.
Why speculate a buyout when they haven’t done anything in a decade but keep some retire doctors titled
Old webpage, old logo, dead link...
What terms?
Sabby=Monster short position
are we back to 3 cents yet?
Crashed through Fibonacci
To the moon.... Guess that is what this board is for.
CEO worked at a small IT support company, doesnt seem like the most likely candidate to run this company to the clouds....
Fun to see how my posts disappear.
Oh look the boards discreditor is awake
Diluted and back to .002
Mother is director at Hopkins, said they haven’t worked with any doctors that worked with Inspyr for many years. She said she thought they went out of business and were just letting the company fizzle out. She said many of the doctors still there work with no pay just to keep a title.
.012 Friday close
Inv groups are fleecing the little traders here on this board.
Why add shared to the market at 1 cent?
Why would they dilute so badly this week and last?
Sabby made $$$ pumping this one
all the funds guy are pumping while slowly dumping...